Loading company…
Nuvaira develops a catheter-based system under clinical investigation for chronic obstructive pulmonary disease.
Founded in 2008, Nuvaira develops the dNerva Lung Denervation System, a catheter-based technology intended for a one-time bronchoscopic procedure to treat COPD. The system is under clinical investigation and is not commercially available in the US. The company is based in Minneapolis, US. In December 2023, it raised USD 15.12 mn in Series F funding.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in